Prospective Study to Identify Efficacy, Safety, and Predictors of Tezepelumab in Severe Asthma
Not Applicable
Recruiting
- Conditions
- asthma, bronchial asthma
- Registration Number
- JPRN-UMIN000049566
- Lead Sponsor
- Japanese Red Cross Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with a history of previous administration of tezepelumab (2) Patients with serious complications such as cardiac, hepatic, or renal disease (3) Patients who are judged to be inappropriate for the subject by the physician's judgment.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Predictors of efficacy before treatment and improvement in symptoms after 16 weeks
- Secondary Outcome Measures
Name Time Method